Comments
Unichem Laboratories on Thursday said it has received approval from the US health regulator to market Divalproex Sodium Delayed Release tablets, indicated for seizure disorders, in the American market.
The company has got the US Food and Drug Administration for Divalproex Sodium Delayed Release tablets in strengths of 125 mg, 250mg and 500 mg, Unichem Laboratories said in a filing to the Bombay Stock Exchange (BSE).
The company already has nine drugs in the US that have been approved by the USFDA, it added.
Shares of Unichem Laboratories were trading at Rs 204.50 on BSE in late afternoon trade, up 4.84 per cent from its previous close.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.